Literature DB >> 33586997

The Impact of the COVID-19 Pandemic on People Living with HIV in Victoria, Australia.

Mihiri Weerasuria1, Christy Ko2, Adam Ehm3, Jessica O'Bryan1,4, James McMahon1,2,4, Ian Woolley1,2,4, Jennifer Hoy1,2, Jillian Lau1,2,4.   

Abstract

As of January 12, 2021, Australia has reported 28,634 COVID-19 cases. Most (20,411) cases are from the state of Victoria. In response to rising infections and community transmission in July 2020, on August 2nd, several restrictions were imposed for the following 111 days, including an 8pm curfew, a travel restriction to 5 km from home, and closure of nonessential services. It is unknown how this affected people living with HIV (PLHIV), who already experience disproportionate levels of mental health issues, comorbidity, and stigma. An online survey was designed with HIV community-based organizations to investigate the impact of the pandemic on Victorian PLHIV. Participants were recruited voluntarily both through social media and Infectious Diseases clinics at participating hospitals. There were 153 respondents. Most were male (77%), aged between 30 and 60 years (77%), and Australian-born (63%). Forty-three percent, 31%, and 25% reported negative impacts upon personal relationships, employment, and income, respectively. HIV care continued with 95% and 98% being able to access their HIV provider and antiretroviral therapy (ART), respectively. Telehealth was used by 92% and was largely well received. PLHIV reported worry about physical health (68%), mental health (66%), finances (50%),z and accommodation (25%). Fifty percent of participants reported weight gain and 27% increased alcohol intake. This study demonstrated the widespread negative effects of the COVID-19 pandemic on PLHIV in Victoria, although provision of HIV care and ART continued uninterrupted. This highlighted the importance of mental health support and social welfare programs during times of health care and societal strain.

Entities:  

Keywords:  COVID-19; HIV; impact; mental health; pandemic

Year:  2021        PMID: 33586997     DOI: 10.1089/AID.2021.0007

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  A qualitative study of the impact of coronavirus disease (COVID-19) on psychological and financial wellbeing and engagement in care among men who have sex with men living with HIV in Thailand.

Authors:  Chattiya Nitpolprasert; Tarandeep Anand; Nittaya Phanuphak; Peter Reiss; Jintanat Ananworanich; Holly Landrum Peay
Journal:  HIV Med       Date:  2021-10-11       Impact factor: 3.094

2.  Access to HIV Antiretroviral Therapy among People Living with HIV in Melbourne during the COVID-19 Pandemic.

Authors:  Dooyeon Lee; Eric P F Chow; Ivette Aguirre; Christopher K Fairley; Jason J Ong
Journal:  Int J Environ Res Public Health       Date:  2021-12-03       Impact factor: 3.390

Review 3.  Social and Behavioral Impacts of COVID-19 on People Living with HIV: Review of the First Year of Research.

Authors:  Seth C Kalichman; Renee El-Krab
Journal:  Curr HIV/AIDS Rep       Date:  2021-11-26       Impact factor: 5.495

4.  Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis.

Authors:  Matthew A Spinelli; Noelle Le Tourneau; David V Glidden; Ling Hsu; Matthew D Hickey; Elizabeth Imbert; Mireya Arreguin; Jennifer P Jain; Jon J Oskarsson; Susan P Buchbinder; Mallory O Johnson; Diane Havlir; Katerina A Christopoulos; Monica Gandhi
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

5.  Impact of SARS-CoV-2 lockdown on expansion of HIV transmission clusters among key populations: A retrospective phylogenetic analysis.

Authors:  Rachel L Miller; Angela McLaughlin; Vincent Montoya; Junine Toy; Sarah Stone; John Harding; Richard H Liang; Jason Wong; Rolando Barrios; Julio S G Montaner; Jeffrey B Joy
Journal:  Lancet Reg Health Am       Date:  2022-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.